Related Experiment Videos
Changes in left ventricular function and mass during serial investigations after valve replacement for aortic
1Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital in Skejby, Denmark.
The Journal of Heart Valve Disease
|August 18, 2000
Summary
Left ventricular hypertrophy regression after aortic stenosis valve replacement is predictable, with significant reduction occurring within 18 months. However, normal ventricular mass is achieved in only a minority of patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Imaging
Background:
- Aortic stenosis often leads to left ventricular hypertrophy.
- Valve replacement aims to reverse this hypertrophy and improve cardiac function.
- Predicting the extent and time course of regression is crucial for patient outcomes.
Purpose of the Study:
- To investigate preoperative predictors of left ventricular hypertrophy regression after aortic valve replacement.
- To analyze the time course of functional changes in the left ventricle post-surgery.
- To identify factors influencing the extent of hypertrophy regression and functional improvement.
Main Methods:
- Prospective follow-up of 46 patients undergoing aortic valve replacement for aortic stenosis.
- Serial echocardiography and radionuclide ventriculography at 8 days, 3 months, and 18 months post-surgery.
- Analysis of left ventricular ejection fraction (EF), fast filling fraction, mass index, and end-diastolic volume index (EDVi) using statistical models.
Main Results:
- Left ventricular ejection fraction (EF) showed a marginal increase, predicted by preoperative EF and fast filling fraction.
- Hypertrophy regression was significant, with mass index decreasing from 200±66 g/m² to 148±49 g/m² at 18 months.
- Regression was influenced by preoperative left ventricular end-systolic dimension index and systolic wall stress, with time-dependent effects.
Conclusions:
- Left ventricular response to aortic valve replacement is predictable.
- Significant hypertrophy regression occurs within 18 months, but normalization of ventricular mass is uncommon.
- Irreversible myocardial disease can limit hypertrophy regression and functional recovery despite successful valve replacement.